Circulating phosphate levels slowly increase with the progression of CKD and both directly and indirectly contribute to the skeletal fragility associated with CKD-MBD, in part via the stimulation of PTH and FGF23 production [78]. This evidence concerns the gene FGF23 and Marchiafava-Bignami disease.